デフォルト表紙
市場調査レポート
商品コード
1666453

骨髄移植の世界市場レポート 2025年

Bone Marrow Transplantation Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
骨髄移植の世界市場レポート 2025年
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

骨髄移植市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.7%で152億5,000万米ドルに成長します。予測期間の成長は、免疫療法の進歩、同種移植の需要増加、非血液性疾患への応用拡大、個別化医療と精密治療、世界の共同研究、パートナーシップなどに起因すると考えられます。予測期間における主な動向には、技術の進歩、同種移植の需要増加、非悪性疾患における用途の拡大、car-t細胞療法の出現、移植前診断の強化などが含まれます。

予想されるがんおよび疾患患者の急増は、骨髄移植手技の拡大を促進すると予想されます。がんは急速かつ制御不能な細胞再生産を特徴とする疾患であるため、骨髄移植は極めて重要な治療法として浮上しています。病気の骨髄を健康な細胞と置き換えることで、骨髄移植はがんやその他の病気の急増に対処する有望な手段となります。2022年、米国がん協会(American Cancer Society Inc.)の報告によると、米国では新たに約190万人のがん患者が発生し、60万9360人のがん関連死が予想されています。このことは、疾病の有病率の上昇に伴い、骨髄移植の進歩が急務であることを強調しています。

急成長している細胞治療試験の分野は、骨髄移植の展望に大きな影響を与えようとしています。これらの臨床試験は、様々な病状を治療するために生きた細胞を利用することの実行可能性と安全性を評価することに重点を置いており、重要な造血幹細胞を供給する能力を持つ骨髄移植に大きく依存しています。これらの細胞は、損傷した細胞の代替、血液疾患への対応、多様な疾患に対する革新的な細胞ベースの治療法の開拓に役立っています。注目すべきは、2023年1月に米国遺伝子・細胞治療学会が発表したデータで、2022年の遺伝子・細胞・RNA治療パイプラインが前臨床から登録前までで7%増加し、開発中の治療法が合計3,726種類に上ることが明らかになったことです。これは、骨髄移植の進歩を推進する細胞治療試験の影響力の予測を補強するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界骨髄移植 PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の骨髄移植市場:成長率分析
  • 世界の骨髄移植市場の実績:規模と成長, 2019-2024
  • 世界の骨髄移植市場の予測:規模と成長, 2024-2029, 2034F
  • 世界骨髄移植総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の骨髄移植市場:製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ファイバ
  • ビタミン
  • オメガ3PUFA
  • 植物エキス
  • 鉱物
  • カロテノイドと抗酸化物質
  • プロバイオティクス
  • その他の製品
  • 世界の骨髄移植市場:ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 植物
  • 動物
  • 微生物
  • 世界の骨髄移植市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 機能性食品・飲料
  • 栄養補助食品
  • 臨床栄養学
  • パーソナルケア
  • その他の用途
  • 世界の骨髄移植市場、自家骨髄移植の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 末梢血幹細胞移植
  • 骨髄採取と保管
  • コンディショニングレジメン
  • 移植後のケア
  • 世界の骨髄移植市場、同種骨髄移植の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 適合兄弟ドナー移植
  • 適合非血縁ドナー移植
  • ハプロタイプ一致移植
  • 臍帯血移植
  • コンディショニングレジメン
  • 移植後のケア

第7章 地域別・国別分析

  • 世界の骨髄移植市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の骨髄移植市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 骨髄移植市場:競合情勢
  • 骨髄移植市場:企業プロファイル
    • Merck Millipore Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • HemaCare Corporation Overview, Products and Services, Strategy and Financial Analysis
    • AllCells LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Lonza Group Ltd.
  • Conversant Bio Company
  • Lifeline Cell Technology LLC
  • Mesoblast Ltd.
  • PromoCell GmbH
  • ATCC Inc.(American Type Culture Collection)
  • Qiagen N.V.
  • ReachBio LLC
  • Gamida Cell Ltd.
  • Abbott Laboratories Inc.
  • The Emmes Company LLC
  • Allogene Therapeutics Inc.
  • Amgen Inc.
  • Angiocrine Biosciences Corp.
  • Astellas Pharma Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 骨髄移植市場2029:新たな機会を提供する国
  • 骨髄移植市場2029:新たな機会を提供するセグメント
  • 骨髄移植市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r23985

Bone marrow transplantation (BMT) is a specialized procedure used in treating individuals with specific malignancies or other conditions, involving the replacement of damaged or unhealthy bone marrow with healthy cells. This treatment is commonly employed for addressing blood cell disorders such as leukemia and lymphoma.

The primary categories of bone marrow transplantation include autologous bone marrow transplant and allogeneic bone marrow transplant. An autologous bone marrow transplant is a medical procedure focused on restoring stem cells that have been impaired by radiation or high doses of chemotherapy in a patient's own body. This type of transplant is indicated for various conditions such as Hodgkin lymphoma, acute leukemia, multiple myeloma, solid tumors, non-Hodgkin lymphoma, among others. These procedures are typically conducted in hospitals, multidisciplinary clinics, and ambulatory surgical centers.

The bone marrow transplantation market research report is one of a series of new reports from The Business Research Company that provides bone marrow transplantation market statistics, including bone marrow transplantation industry global market size, regional shares, competitors with a bone marrow transplantation market share, detailed bone marrow transplantation market segments, market trends and opportunities, and any further data you may need to thrive in the bone marrow transplantation industry. This bone marrow transplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bone marrow transplantation market size has grown strongly in recent years. It will grow from$11.61 billion in 2024 to $12.23 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increasing prevalence of hematologic disorders, improved healthcare infrastructure, rising awareness and education, aging population, government initiatives and support

The bone marrow transplantation market size is expected to see strong growth in the next few years. It will grow to $15.25 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to advancements in immunotherapy, increasing demand for allogeneic transplants, expanding applications in non-hematologic diseases, personalized medicine and precision therapeutics, global collaboration, and partnerships. Major trends in the forecast period include technological advancements, increasing demand for allogeneic transplants, rising applications in non-malignant diseases, emergence of car-t cell therapies, enhanced pre-transplant diagnostics.

The anticipated surge in cancer and disease cases is expected to drive the expansion of bone marrow transplantation procedures. With cancer being a condition characterized by rapid and uncontrolled cell reproduction, bone marrow transplants emerge as a crucial treatment method. By replacing diseased bone marrow with healthy cells, these transplants offer a promising avenue for addressing the escalating incidences of cancer and other ailments. In 2022, reports from the American Cancer Society Inc. estimated approximately 1.9 million new cancer cases in the US, resulting in an anticipated 609,360 cancer-related deaths. This underscores the pressing need for advancements in bone marrow transplantation, aligning with the rising prevalence of diseases.

The burgeoning field of cell therapy trials is poised to significantly impact the landscape of bone marrow transplantation. These trials, focused on assessing the viability and safety of utilizing living cells to treat various medical conditions, heavily rely on bone marrow transplantation for its capacity to supply vital hematopoietic stem cells. These cells are instrumental in replacing damaged cells, addressing blood disorders, and pioneering innovative cell-based therapies for diverse ailments. Notably, data from the American Society of Gene & Cell Therapy in January 2023 highlighted a 7% growth in the gene, cell, and RNA therapy pipeline from preclinical to pre-registration in 2022, totaling 3,726 therapies in development. This reinforces the projected influence of cell therapy trials on propelling advancements in bone marrow transplantation.

Technological advancements emerge as a prominent trend reshaping the landscape of bone marrow transplantation. Key players in the healthcare sector are actively engaged in developing and introducing innovative technologies, aiming to fortify their market presence. An exemplar is the collaborative effort between BioIntelliSense and UC Davis Health in November 2023. Their joint initiative introduces continuous monitoring for bone marrow transplant patients, employing BioIntelliSense's FDA-cleared BioButton wearable devices coupled with algorithm-based data analytics. This proactive approach enables real-time detection of subtle changes in vital signs, facilitating timely interventions and informed clinical decisions for enhanced patient care.

Strategic partnerships have emerged as a driving force in augmenting access and broadening treatment options within the bone marrow transplantation industry. Companies are leveraging mutual strengths and resources through partnerships to achieve collective advancements. An illustrative partnership occurred in August 2023 between Ossium Health and Be the Match BioTherapies. This collaboration aims to bolster accessibility to bone marrow transplants and enhance treatment efficacy. By pooling resources, Ossium Health and Be the Match BioTherapies endeavor to extend life-saving treatments to a wider spectrum of patients, thereby significantly amplifying their reach and impact in the healthcare landscape.

In October 2024, Werfen, a medical diagnostics company based in Spain, acquired Omixon Bioinformatics Ltd. for $25 million. This acquisition is intended to expand Werfen's portfolio in transplant diagnostics, improving precision and efficiency in bone marrow transplantation processes to enhance patient outcomes. Omixon Bioinformatics Ltd., located in Hungary, specializes in transplant diagnostics and provides genetic and immunological testing solutions to ensure compatibility for organ and bone marrow transplants.

Major companies operating in the bone marrow transplantation market include Merck Millipore Corporation, Sanofi SA, STEMCELL Technologies Inc., HemaCare Corporation, AllCells LLC, Lonza Group Ltd., Conversant Bio Company, Lifeline Cell Technology LLC, Mesoblast Ltd., PromoCell GmbH, ATCC Inc. (American Type Culture Collection), Qiagen N.V., ReachBio LLC, Gamida Cell Ltd., Abbott Laboratories Inc., The Emmes Company LLC, Allogene Therapeutics Inc., Amgen Inc., Angiocrine Biosciences Corp., Astellas Pharma Inc., Atara Biotherapeutics Inc., Bluebird Bio Inc., Cellectis S.A., Celyad SA, Erythrocyte Regeneration and Clinical Therapeutics Inc., Gammacell AB, Gilead Sciences Inc., Graphite Bio Inc., Incyte Corporation, Intellia Therapeutics Inc., Legend Biotech Corporation, Magenta Therapeutics Inc., Novartis AG

North America was the largest region in the bone marrow transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global bone marrow transplantation market report forecast period. The regions covered in the bone marrow transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bone marrow transplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The bone marrow transplantation market includes revenues earned by providing transplantation services syngeneic transplants, allogeneic transplants, autologous transplants, haploidentical transplants, non-myeloablative transplants, and umbilical cord blood transplants. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bone Marrow Transplantation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bone marrow transplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bone marrow transplantation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bone marrow transplantation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Autologous Bone Marrow Transplant; Allogenic Bone Marrow Transplant
  • 2) By Indication: Hodgkin Lymphoma; Acute Leukemia; Multiple Myelomas; Solid Tumors; Non-Hodgkin Lymphoma; Other Indications
  • 3) By End-Users: Hospitals; Multispecialty Clinics; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Autologous Bone Marrow Transplant: Peripheral Blood Stem Cell Transplant; Bone Marrow Harvesting And Storage; Conditioning Regimens; Post-Transplant Care
  • 2) By Allogenic Bone Marrow Transplant: Matched Sibling Donor Transplant; Matched Unrelated Donor Transplant; Haploidentical Transplant; Cord Blood Transplant; Conditioning Regimens; Post-Transplant Care
  • Companies Mentioned: Merck Millipore Corporation; Sanofi SA; STEMCELL Technologies Inc.; HemaCare Corporation; AllCells LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bone Marrow Transplantation Market Characteristics

3. Bone Marrow Transplantation Market Trends And Strategies

4. Bone Marrow Transplantation Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Bone Marrow Transplantation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bone Marrow Transplantation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bone Marrow Transplantation Market Growth Rate Analysis
  • 5.4. Global Bone Marrow Transplantation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bone Marrow Transplantation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bone Marrow Transplantation Total Addressable Market (TAM)

6. Bone Marrow Transplantation Market Segmentation

  • 6.1. Global Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fiber
  • Vitamins
  • Omega 3 PUFA
  • Plant Extracts
  • Minerals
  • Carotenoids And Antioxidants
  • Probiotics
  • Other Products
  • 6.2. Global Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plant
  • Animal
  • Microbial
  • 6.3. Global Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Functional Food And Beverage
  • Dietary Supplements
  • Clinical Nutrition
  • Personal Care
  • Other Applications
  • 6.4. Global Bone Marrow Transplantation Market, Sub-Segmentation Of Autologous Bone Marrow Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Peripheral Blood Stem Cell Transplant
  • Bone Marrow Harvesting And Storage
  • Conditioning Regimens
  • Post-Transplant Care
  • 6.5. Global Bone Marrow Transplantation Market, Sub-Segmentation Of Allogenic Bone Marrow Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Matched Sibling Donor Transplant
  • Matched Unrelated Donor Transplant
  • Haploidentical Transplant
  • Cord Blood Transplant
  • Conditioning Regimens
  • Post-Transplant Care

7. Bone Marrow Transplantation Market Regional And Country Analysis

  • 7.1. Global Bone Marrow Transplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bone Marrow Transplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bone Marrow Transplantation Market

  • 8.1. Asia-Pacific Bone Marrow Transplantation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bone Marrow Transplantation Market

  • 9.1. China Bone Marrow Transplantation Market Overview
  • 9.2. China Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bone Marrow Transplantation Market

  • 10.1. India Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bone Marrow Transplantation Market

  • 11.1. Japan Bone Marrow Transplantation Market Overview
  • 11.2. Japan Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bone Marrow Transplantation Market

  • 12.1. Australia Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bone Marrow Transplantation Market

  • 13.1. Indonesia Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bone Marrow Transplantation Market

  • 14.1. South Korea Bone Marrow Transplantation Market Overview
  • 14.2. South Korea Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bone Marrow Transplantation Market

  • 15.1. Western Europe Bone Marrow Transplantation Market Overview
  • 15.2. Western Europe Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bone Marrow Transplantation Market

  • 16.1. UK Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bone Marrow Transplantation Market

  • 17.1. Germany Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bone Marrow Transplantation Market

  • 18.1. France Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bone Marrow Transplantation Market

  • 19.1. Italy Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bone Marrow Transplantation Market

  • 20.1. Spain Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bone Marrow Transplantation Market

  • 21.1. Eastern Europe Bone Marrow Transplantation Market Overview
  • 21.2. Eastern Europe Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bone Marrow Transplantation Market

  • 22.1. Russia Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bone Marrow Transplantation Market

  • 23.1. North America Bone Marrow Transplantation Market Overview
  • 23.2. North America Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bone Marrow Transplantation Market

  • 24.1. USA Bone Marrow Transplantation Market Overview
  • 24.2. USA Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bone Marrow Transplantation Market

  • 25.1. Canada Bone Marrow Transplantation Market Overview
  • 25.2. Canada Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bone Marrow Transplantation Market

  • 26.1. South America Bone Marrow Transplantation Market Overview
  • 26.2. South America Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bone Marrow Transplantation Market

  • 27.1. Brazil Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bone Marrow Transplantation Market

  • 28.1. Middle East Bone Marrow Transplantation Market Overview
  • 28.2. Middle East Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bone Marrow Transplantation Market

  • 29.1. Africa Bone Marrow Transplantation Market Overview
  • 29.2. Africa Bone Marrow Transplantation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bone Marrow Transplantation Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Bone Marrow Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bone Marrow Transplantation Market Competitive Landscape And Company Profiles

  • 30.1. Bone Marrow Transplantation Market Competitive Landscape
  • 30.2. Bone Marrow Transplantation Market Company Profiles
    • 30.2.1. Merck Millipore Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. HemaCare Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AllCells LLC Overview, Products and Services, Strategy and Financial Analysis

31. Bone Marrow Transplantation Market Other Major And Innovative Companies

  • 31.1. Lonza Group Ltd.
  • 31.2. Conversant Bio Company
  • 31.3. Lifeline Cell Technology LLC
  • 31.4. Mesoblast Ltd.
  • 31.5. PromoCell GmbH
  • 31.6. ATCC Inc. (American Type Culture Collection)
  • 31.7. Qiagen N.V.
  • 31.8. ReachBio LLC
  • 31.9. Gamida Cell Ltd.
  • 31.10. Abbott Laboratories Inc.
  • 31.11. The Emmes Company LLC
  • 31.12. Allogene Therapeutics Inc.
  • 31.13. Amgen Inc.
  • 31.14. Angiocrine Biosciences Corp.
  • 31.15. Astellas Pharma Inc.

32. Global Bone Marrow Transplantation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bone Marrow Transplantation Market

34. Recent Developments In The Bone Marrow Transplantation Market

35. Bone Marrow Transplantation Market High Potential Countries, Segments and Strategies

  • 35.1 Bone Marrow Transplantation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bone Marrow Transplantation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bone Marrow Transplantation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer